The Long-term Success of Cardiovascular Surgery in Takayasu Arteritis

NCT ID: NCT03654222

Last Updated: 2018-08-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

66 participants

Study Classification

OBSERVATIONAL

Study Start Date

1977-01-01

Study Completion Date

2017-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Takayasu Arteritis (TA) affects medium and large caliber arteries causing stenosis, occlusion or aneurysms. It has great predilection for the aortic arch, subclavian and extracranial arteries. The global prevalence is of 1 to 2% per million inhabitants, which varies by geographical region. The main cause of death in TA is of cardiovascular origin and includes ischemic cardiomyopathy and valvular disease. The aim of this study was to evaluate the surgical experience according to the type of surgery in subjects with TA with and without inflammatory activity.

Methods: This was a retrospective, descriptive, cross-sectional study run between 1977 and 2017. Patients with Takayasu arteritis with more than 3 classification criteria according to the American College of Rheumatology (ACR) were included. The surgeries were classified as: Organ preservation, cardiac, bypass, exclusion and replacement. Inflammatory activity was evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A review of the clinical records of patients diagnosed with TA with more than 3 criteria of the American College of Rheumatology (ACR) and undergoing some surgical procedure by the Surgery Service of the National Institute of Cardiology "Ignacio Chávez", in a period of time comprised between 1977 and 2016 was done. Patients of any gender and age who had been operated on by a surgical procedure registered in their medical record were included. Patients intervened in other institutions were excluded. The surgical event was classified into 6 groups: 1) organ-preservation surgery (mainly renal autograft); 2) Bypass (revascularization of affected organs or segments with Woven Dacron graft); 3) Replacement (replacement of affected aortic segment with a Woven Dacron graft); 4) Cardiac Surgery (direct procedures in heart); 5) Exclusion (resection of an affected organ (nephrectomy)), and 6) Other.

Inflammatory activity was evaluated according to the Dabague-Reyes criteria, in which a score greater than or equal to 5 is considered as active inflammation (9).

Statistical analysis: Variables with a loss of the sample data greater than 20% were excluded. The categorical variables were described by percentages and prevalences and the comparison were done by chi square or Fisher's exact test. A statistically significant level was considered when an error α \<0.05 was found. Parametric numerical variables are described by measures of central tendency and the comparison is made by Student's T test. The survival analysis was performed using Kaplan-Meier. Ethical aspects were considered according to the Helsinky declaration.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteritis, Takayasu

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiac surgery

Direct procedures in heart

No interventions assigned to this group

Organ preservation

Mainly renal autograft

No interventions assigned to this group

Bypass

Revascularization of affected organs or segments with Woven Dacron graft

No interventions assigned to this group

Exclusion

Resection of an affected organ (nephrectomy)

No interventions assigned to this group

Replacement

Replacement of affected aortic segment with a Woven Dacron graft

No interventions assigned to this group

Other

Any surgery that does not include the previous ones

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of any gender regardless of age that has a diagnosis of TA established by a rheumatologist,
* Have a surgical procedure registered in your medical record

Exclusion Criteria

* Not having a digital, physical or microfilmed medical record
* Surgical procedures performed at another institution
Minimum Eligible Age

10 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maria Elena Soto, MsC and PhD

RESEARCH DOCTOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nacional Institute of Cardiology

Mexico City, Mexico City, Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

References

Explore related publications, articles, or registry entries linked to this study.

Serra R, Butrico L, Fugetto F, Chibireva MD, Malva A, De Caridi G, Massara M, Barbetta A, Cannistra M, de Franciscis S. Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Ann Vasc Surg. 2016 Aug;35:210-25. doi: 10.1016/j.avsg.2016.02.011. Epub 2016 May 27.

Reference Type BACKGROUND
PMID: 27238990 (View on PubMed)

Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol. 1996 Aug;54 Suppl:S99-102. doi: 10.1016/s0167-5273(96)88778-x.

Reference Type BACKGROUND
PMID: 9119532 (View on PubMed)

Lazzarin P, Pasero G, Marson P, Cecchetto A, Zanchin G. [Takayasu's arteritis. A concise review and some observations on a putative case reported by Giovanni Battista Morgagni (1761)]. Reumatismo. 2005 Dec;57(4):305-13. doi: 10.4081/reumatismo.2005.305. Italian.

Reference Type BACKGROUND
PMID: 16380760 (View on PubMed)

SHIMIZU K, SANO K. Pulseless disease. J Neuropathol Clin Neurol. 1951 Jan;1(1):37-47. No abstract available.

Reference Type BACKGROUND
PMID: 24538949 (View on PubMed)

Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996 Aug;54 Suppl:S141-7. doi: 10.1016/s0167-5273(96)88783-3.

Reference Type BACKGROUND
PMID: 9119516 (View on PubMed)

Park SJ, Kim HJ, Park H, Hann HJ, Kim KH, Han S, Kim Y, Ahn HS. Corrigendum to "Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study" [Int. J. Cardiol., 235(2017), 100-104]. Int J Cardiol. 2017 Jul 1;238:182. doi: 10.1016/j.ijcard.2017.04.013. Epub 2017 Apr 24. No abstract available.

Reference Type BACKGROUND
PMID: 28449826 (View on PubMed)

Dabague J, Reyes PA. Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review. Int J Cardiol. 1996 Aug;54 Suppl:S103-9. doi: 10.1016/s0167-5273(96)88779-1.

Reference Type BACKGROUND
PMID: 9119510 (View on PubMed)

Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S9-15.

Reference Type BACKGROUND
PMID: 18799047 (View on PubMed)

Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977 Jan;93(1):94-103. doi: 10.1016/s0002-8703(77)80178-6.

Reference Type BACKGROUND
PMID: 12655 (View on PubMed)

Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013 Aug;88(8):822-30. doi: 10.1016/j.mayocp.2013.04.025. Epub 2013 Jul 10.

Reference Type BACKGROUND
PMID: 23849994 (View on PubMed)

Nazareth R, Mason JC. Takayasu arteritis: severe consequences of delayed diagnosis. QJM. 2011 Sep;104(9):797-800. doi: 10.1093/qjmed/hcq193. Epub 2010 Oct 15. No abstract available.

Reference Type BACKGROUND
PMID: 20952441 (View on PubMed)

Rosa Neto NS, Shinjo SK, Levy-Neto M, Pereira RMR. Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients. Rheumatol Int. 2017 Jul;37(7):1065-1073. doi: 10.1007/s00296-017-3656-y. Epub 2017 Feb 21.

Reference Type BACKGROUND
PMID: 28224216 (View on PubMed)

Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, Ishibashi-Ueda H, Kobayashi J, Yagihara T, Kitamura S. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation. 2008 Dec 16;118(25):2738-47. doi: 10.1161/CIRCULATIONAHA.107.759589. No abstract available.

Reference Type BACKGROUND
PMID: 19106398 (View on PubMed)

Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation. 1978 Jan;57(1):27-35. doi: 10.1161/01.cir.57.1.27.

Reference Type BACKGROUND
PMID: 21760 (View on PubMed)

Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, Mignot C, Schoindre Y, Chiche L, Hatron PY, Emmerich J, Cacoub P. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012 Feb 14;125(6):813-9. doi: 10.1161/CIRCULATIONAHA.111.058032. Epub 2012 Jan 9.

Reference Type BACKGROUND
PMID: 22230484 (View on PubMed)

Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, Kahn D. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005 Mar;75(3):110-7. doi: 10.1111/j.1445-2197.2005.03312.x.

Reference Type BACKGROUND
PMID: 15777385 (View on PubMed)

Kaku Y, Aomi S, Tomioka H, Yamazaki K. Surgery for aortic regurgitation and aortic root dilatation in Takayasu arteritis. Asian Cardiovasc Thorac Ann. 2015 Oct;23(8):901-6. doi: 10.1177/0218492315591291. Epub 2015 Jun 18.

Reference Type BACKGROUND
PMID: 26089524 (View on PubMed)

Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation. 2003 Sep 23;108(12):1474-80. doi: 10.1161/01.CIR.0000089089.42153.5E. Epub 2003 Sep 2.

Reference Type BACKGROUND
PMID: 12952846 (View on PubMed)

Li J, Zhu M, Li M, Zheng W, Zhao J, Tian X, Zeng X. Cause of death in Chinese Takayasu arteritis patients. Medicine (Baltimore). 2016 Jul;95(27):e4069. doi: 10.1097/MD.0000000000004069.

Reference Type BACKGROUND
PMID: 27399093 (View on PubMed)

Chiche L, Kieffer E, Sabatier J, Colau A, Koskas F, Bahnini A. Renal autotransplantation for vascular disease: late outcome according to etiology. J Vasc Surg. 2003 Feb;37(2):353-61. doi: 10.1067/mva.2003.84.

Reference Type BACKGROUND
PMID: 12563206 (View on PubMed)

Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010 Jan;56(1):3-23. doi: 10.1111/j.1365-2559.2009.03443.x.

Reference Type RESULT
PMID: 20055902 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20142018

Identifier Type: -

Identifier Source: org_study_id